Soluble Expression and Purification of Receptor Activator of Nuclear Factor-Kappa B Ligand Using Escherichia coli |
Park, Sol-Ji
(Department of Food Science and Technology, Sunchon National University)
Lee, Se-Hoon (Department of Pharmacy, Sunchon National University) Kim, Kwang-Jin (Department of Pharmacy, Sunchon National University) Kim, Sung-Gun (Department of Biomedical Science, Youngdong University) Kim, Hangun (Department of Pharmacy, Sunchon National University) Choe, Han (Department of Physiology and Bio-Medical Institute of Technology, University of Ulsan College of Medicine) Lee, Sang Yeol (Department of Life Science, Gachon University) Yun, Jung-Mi (Department of Food and Nutrition, Kwangju Women's University) Cho, Jae Youl (Department of Genetic Engineering, Sungkyunkwan University) Chun, Jiyeon (Department of Food Science and Technology, Sunchon National University) Choi, Kap Seong (Department of Food Science and Technology, Sunchon National University) Son, Young-Jin (Department of Pharmacy, Sunchon National University) |
1 | Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323. DOI ScienceOn |
2 | O’Brien CA, Nakashima T, Takayanagi H. 2012. Osteocyte control of osteoclastogenesis. Bone 54: 258-263. DOI ScienceOn |
3 | Smith DM, Nance WE, Kang KW. 1973. Genetic factors in determining bone mass. J. Clin. Invest. 52: 2800-2808. DOI ScienceOn |
4 | Wardlaw G. 1988. The effects of diet and life-style on bone mass in women. J. Am. Diet. Assoc. 88: 17-25. |
5 | Willard D, Chen WJ, Barrett G, Blackburn K, Bynum J, Consler T, et al. 2000. Expression, purification, and characterization of the human receptor activator of NF-KB ligand (RANKL) extracellular domain. Protein Expr. Purif. 20: 48-57. DOI ScienceOn |
6 | Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272: 25190-25194. DOI ScienceOn |
7 | Xiong J, Charles AO. 2012. Osteocyte RANKL: new insights into the control of bone remodeling. J. Bone Miner. Res. 27: 499-505. DOI |
8 | Ilich JZ, Kerstetter JE. 2000. Nutrition in bone health revisited: a story beyond calcium. J. Am. Coll. Nutr. 19: 715-737. DOI |
9 | Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, et al. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179. DOI ScienceOn |
10 | Boyce BF, Xing L. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473: 139-146. DOI ScienceOn |
11 | Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, et al. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50. DOI ScienceOn |
12 | Gallagher JC, Riggs BL, Eisman J. 1994. Diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 90: 646-650. |
13 | Grigoriades AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448. DOI |
14 | Jeong TH, Son YJ, Ryu HB, Koo BK, Jeong SM, Hoang P, et al. 2014. Soluble expression and partial purification of recombinant human erythropoietin from E. coli. Protein Expr. Purif. 95: 211-218. DOI ScienceOn |
15 | Kanamaru F, Iwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M. 2004. Expression of membrane-bound and soluble receptor activator of NF-kappa B ligand (RANKL) in human T cells. Immun. Lett. 94: 239-246. DOI ScienceOn |
16 | Kim NS, Kim HJ, Koo BK, Kwon MC, Kim YW, Cho Y, et al. 2006. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells. Mol. Cell. Biol. 26: 1002-1013. DOI ScienceOn |
![]() |